TORONTO (AP) — Canada will sooner or later be capable to manufacture COVID-19 vaccines, Primary Minister Justin Trudeau stated Tuesday, as his federal government faces issues about finding doses from Europe.
Canada does not have domestic production but Trudeau expects to use doses built in Europe to vaccinate all Canadians who want to be vaccinated by September. Trudeau reiterated Tuesday the European Union reassured him that it will respect Canada’s contracts with Pfizer and Moderna. The EU has talked about tightening rules on exports of vaccines.
The key minister said Canada wants as a lot domestic capability for vaccine generation as quickly as possible simply because with new variants they really don’t know what the potential appears to be like a 12 months or two from now.
Trudeau said two companies – Precision NanoSystems and Novavax – will at some point manufacture vaccines in Canada.
He reported they have signed a memorandum of understanding with Maryland-primarily based Novavax and pending Health Canada acceptance, tens of tens of millions of Novavax COVID-19 doses will be manufactured in Canada.
Canadian Foreign Minister François-Philippe Champagne afterwards explained Canada will be in a placement by the stop of the year to start off output and could create 2 million vaccines a thirty day period if the vaccine and plant are permitted by the country’s well being regulator.
Trudeau stated Vancouver-centered Precision NanoSystems will also build a producing facility able of manufacturing up to 240 million doses of vaccine for every calendar year.
“I’m glad that we are ultimately starting off to do this,” Ontario Leading Doug Ford reported.